MRLN Merlin, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$1.71
· of 52w range
· above low
· to high
$1.7052w low
$17.0052w high
Market Cap (MRQ)
$172M
your badges
52W Range
$2–$17
Analyst Rating
BUY
Price Target
$9
P/E
·
ROE
-62.9%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
MRLN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.71
Market Cap (MRQ)
$172M
ROE
-62.9%
Debt/Equity (MRQ)
-0.0
52W Range
$2–$17
MRLN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | MRLN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | -1.7 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | MRLN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | 2.3% | · | · | · | |
| ROE | -62.9% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | MRLN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | -0.0 | · | · | · | |
| Current Ratio (MRQ) | 14.7 | · | · | · | |
| Quick Ratio (MRQ) | 14.3 | · | · | · | |
| Long-Term Debt / Equity (MRQ) | -0.0 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-345.4%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-1.40 | $-0.28 | -408.4% |
| March 31, 2026 | May 14, 2026 | $-0.39 | $-0.10 | -282.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 |
|---|---|---|
| SG&A Expense | $4M | |
| Operating Income | $-4M | |
| Interest Income | $56.0K | |
| Other Non-op | $10M | |
| Net Income | $6M | |
| EBITDA | $-4M |
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $59M | |
| Short-term Investments | $330.0K | |
| Receivables | $368.0K | |
| Prepaid Expense | $3M | |
| Current Assets | $71M | |
| PP&E (Net) | $7M | |
| PP&E (Gross) | $12M | |
| Accum. Depreciation | $5M | |
| Total Assets | $81M | |
| Accounts Payable | $3M | |
| Accrued Liabilities | $8M | |
| Short-term Debt | $29M | |
| Current Liabilities | $64M | |
| Capital Leases | $331.0K | |
| Total Liabilities | $154M | |
| Long-term Debt | $32M | |
| Common Stock | $7.0K | |
| Paid-in Capital | $477M | |
| Retained Earnings | $-551M | |
| Stockholders' Equity | $-74M | |
| Liabilities + Equity | $81M | |
| Shares Outstanding | 69,663,395 |
Cash Flow
| Metric | Trend | 2025 |
|---|---|---|
| Stock-based Comp | $670.0K | |
| Operating Cash Flow | $-1M | |
| Financing Cash Flow | $-75.0K |
Profitability
| Metric | Trend | 2025 |
|---|---|---|
| ROA | 2.3% | |
| ROE | -62.9% |
Liquidity & Solvency
| Metric | Trend | 2025 |
|---|---|---|
| Current Ratio | 0.3 | |
| Quick Ratio | 0.2 |
Valuation (TTM)
| Metric | Trend | 2025 |
|---|---|---|
| Net Income TTM | $6M |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | · | $3M | $868.0K | |
| Cost of Revenue | $2M | $2M | · | $3M | $714.0K | |
| Gross Profit | $-119.0K | $2M | · | $41.0K | $154.0K | |
| R&D Expense | $16M | $14M | · | $7M | $7M | |
| SG&A Expense | $16M | $14M | $3M | $4M | $5M | |
| Operating Expenses | $33M | $29M | · | $11M | $12M | |
| Operating Income | $-34M | $-27M | $-3M | $-11M | $-11M | |
| Interest Income | $1M | $517.0K | $14.0K | $131.0K | $301.0K | |
| Other Non-op | $-25M | $-128.0K | $3M | $-5M | $-61.0K | |
| Pretax Income | $-58M | $-90M | · | $-16M | $-13M | |
| Income Tax | $125.0K | $48.0K | · | $1.0K | $1.0K | |
| Net Income | $-58M | $-90M | $83.7K | $-16M | $-13M | |
| EPS (Basic) | $-1.40 | $-1.27 | · | $-0.23 | $-0.18 | |
| EPS (Diluted) | $-1.40 | $-1.27 | · | $-0.23 | $-0.18 | |
| Shares (Basic) | 91,309,267 | 72,421,272 | · | 70,965,177 | 70,947,705 | |
| Shares (Diluted) | 91,309,267 | 72,421,272 | · | 70,965,177 | 70,947,705 | |
| EBITDA | $-34M | $-27M | $-3M | $-357.8K | $-239.3K |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $184M | $123M | $1M | $2M | · | |
| Short-term Investments | $321.0K | $325.0K | · | · | · | |
| Receivables | $2M | $1M | · | · | · | |
| Prepaid Expense | $5M | $6M | $23.6K | $47.9K | $82.2K | |
| Current Assets | $191M | $130M | $1M | $2M | $2M | |
| PP&E (Net) | $11M | $10M | · | · | · | |
| PP&E (Gross) | $18M | $16M | · | · | · | |
| Accum. Depreciation | $6M | $6M | · | · | · | |
| Total Assets | $207M | $145M | $261M | $259M | $257M | |
| Accounts Payable | $6M | $7M | · | · | · | |
| Accrued Liabilities | $6M | $6M | $2M | $146.3K | · | |
| Short-term Debt | $0 | · | · | · | · | |
| Current Liabilities | $13M | $15M | $3M | $1M | $1M | |
| Capital Leases | $1M | $1M | · | · | · | |
| Total Liabilities | $144M | $104M | $12M | $10M | $10M | |
| Long-term Debt | $0 | · | · | · | · | |
| Total Debt | $0 | · | · | · | · | |
| Common Stock | $10.0K | $8.0K | · | · | · | |
| Paid-in Capital | $600M | · | · | · | · | |
| Retained Earnings | $-700M | $-641M | $-11M | $-8M | $-8M | |
| Stockholders' Equity | $-100M | $-139M | $-11M | $-8M | $-8M | |
| Liabilities + Equity | $207M | $145M | $261M | $259M | $257M | |
| Shares Outstanding | 100,592,160 | 70,959,389 | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| D&A | · | $417.0K | · | · | $381.0K | |
| Stock-based Comp | $5M | $1M | · | $433.0K | $513.0K | |
| Other Non-cash | · | $65M | · | · | · | |
| Operating Cash Flow | $-27M | $-24M | $-703.8K | $-117.3K | $-13M | |
| CapEx | $2M | $2M | · | $17.0K | $94.0K | |
| Investing Cash Flow | $-2M | $-2M | · | $-17.0K | $-79.0K | |
| Net Debt Issued | · | $-34M | · | · | · | |
| Stock Repurchased | · | $9M | · | · | · | |
| Net Stock Activity | · | $-9M | · | · | · | |
| Financing Cash Flow | $90M | $92M | · | $-4M | $-2M | |
| Free Cash Flow | · | $-26M | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Gross Margin | -5.4% | 180.9% | · | · | · | |
| Operating Margin | -1528.6% | -2695.8% | · | · | · | |
| Net Margin | -2663.0% | -9023.9% | · | · | · | |
| Pretax Margin | -2657.3% | -9019.1% | · | · | · | |
| EBITDA Margin | -1528.6% | -2654.2% | · | · | · | |
| ROA | -25.1% | -45.0% | 0.06% | 1.8% | 1.9% | |
| ROE | 108.3% | 123.3% | -1.6% | -58.2% | -63.7% | |
| ROIC | 33.6% | 19.4% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 14.7 | 8.7 | 0.4 | 1.6 | 2.0 | |
| Quick Ratio | 14.3 | 8.3 | 0.3 | 1.4 | · | |
| Debt / Equity | 0.0 | · | · | · | · | |
| LT Debt / Equity | 0.0 | · | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 2.5 | 1.5 | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Book Value / Share | $-0.99 | $-1.96 | · | · | · | |
| Revenue / Share | $0.02 | $0.01 | · | · | · | |
| Cash Flow / Share | · | $-0.33 | · | · | · | |
| Cash / Share | $1.82 | $1.73 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-148M | $-105M | · | · | · | |
| Market Cap | $572M | · | · | · | · | |
| Enterprise Value | $388M | · | · | · | · | |
| P/B | -5.7 | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income | $6M | · |
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Current Ratio | 0.3 | 2.1 |
| Quick Ratio | 0.2 | 2.0 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Matthew George | March 23, 2026 | 17.70% | Initial filing | Passive investment | SEC |
| Bleichroeder Sponsor 1 LLC, Andrew Gundlach, Michel Combes | Nov. 12, 2024 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 11 insiders · 4 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Matthew George | Chief Executive Officer | Sept. 16, 2026 F | 15,420,961 | 0 | 0 | $0 |
| Ryan Michael Carrithers | CFO & Treasurer | Sept. 16, 2026 F | 255,343 | 0 | 0 | $0 |
| Leslie Renee Ravestein | CLO and Secretary | Sept. 16, 2026 F | 197,935 | 0 | 0 | $0 |
| Mark Rawlins Brunner | Chief Revenue Officer | May 20, 2026 A | 225,904 | 0 | 0 | $0 |
| Michael Blitzer | Director | Sept. 16, 2026 J | 300,000 | 0 | 0 | $0 |
| Kenneth John Braithwaite | Director | May 20, 2026 A | 37,500 | 0 | 0 | $0 |
| Robert Hanson Smith | Director | May 20, 2026 A | 37,500 | 0 | 0 | $0 |
| Carolyn Trabuco | Director | May 20, 2026 A | 37,500 | 0 | 0 | $0 |
| Kelyn Brannon | Director | May 20, 2026 A | 37,500 | 0 | 0 | $0 |
| Michael Montelongo | Director | May 20, 2026 A | 37,500 | 0 | 0 | $0 |
| FR Capital Holdings, L.P. | 10% owner | Sept. 16, 2026 J | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
MRLN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$8.50
+397.1%
2 20.0%
Strong Buy
7 70.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-03Mean target $8.58 +401.9%
← Below all targets
Current price $1.71
Low$7.00
Mean$8.58
High$10.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026